AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2012
Mar 8, 2012
31982_dirs_2012-03-08_07881d6f-9b82-432b-ab06-c0934491d594.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2012-03-01
Reporting Person: MARSH JOHN O JR (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-01 | Options-right to buy | $1.28 | A | 20000 | Acquired | 2022-03-01 | Common Stock (20000) | Direct |
Footnotes
F1: Exercisable 6 months from date of grant.